Press releases | WebDisclosure

Basculer en Français

10372	Companies
216173	Keywords
145882	Articles
114461	Press releases

Home
Press releases

PRESS RELEASE

published on 12/22/2025 at 07:30, 4 months 19 days ago

EUROPLASMA: KNDS France renouvelle son engagement auprès des Forges de Tarbes
KNDS France renouvelle son engagement avec Les Forges de Tarbes pour la production de munitions d'artillerie de 155mm via un contrat de 3 ans renouvelable, visant à répondre aux besoins de l'économie de guerre

Contrat Production Les Forges De Tarbes MUNITIONS KNDS France
PRESS RELEASE

published on 12/22/2025 at 07:30, 4 months 19 days ago

Mutares signs an agreement to acquire the Gas Solutions business from Wärtsilä
Mutares SE & Co. KGaA acquires Gas Solutions business from Wärtsilä, strengthening position in energy and marine tech sectors. Expected closing in H1 2026

Acquisition Energy Transition Mutares Wärtsilä Gas Solutions
PRESS RELEASE

published on 12/22/2025 at 07:30, 4 months 19 days ago

Chiffre d'affaires 2024/25 : amélioration de la dynamique commerciale au second semestre
écomiam publie son chiffre d'affaires de 38,2 M€ pour 2024/25, avec une amélioration au second semestre et des actions visant à renforcer la performance opérationnelle

Chiffre D'affaires Performance Opérationnelle Écomiam Amélioration Réseau
PRESS RELEASE

published on 12/22/2025 at 07:00, 4 months 19 days ago

VIB Vermögen AG sells logistics property in Großmehring
VIB Vermögen AG sells logistics property in Großmehring to a European investor. Sale of site at Junkers-Ring 7 near A9 motorway. Transaction to be completed in Q1 2026

Sale VIB Vermögen AG Logistics Property European Investor Großmehring
PRESS RELEASE

published on 12/22/2025 at 07:00, 4 months 19 days ago

Inside Information / Other news releases
GenSight Biologics receives Compassionate Use Authorization in France for GS010/LUMEVOQ® gene therapy indicated for ND4-LHON treatment

France GenSight Biologics GS010/LUMEVOQ® Compassionate Use Authorization ND4-LHON
PRESS RELEASE

published on 12/22/2025 at 07:00, 4 months 19 days ago

Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
Ipsen expands pipeline with Simcere Zaiming's novel antibody drug conjugate SIM0613 targeting LRRC15 protein for enhanced tumor penetration and anti-tumor activity. Phase I expected in H2 2026

Ipsen Antibody Drug Conjugate SIM0613 Simcere Zaiming LRRC15
PRESS RELEASE

published on 12/22/2025 at 07:00, 4 months 19 days ago

Informations privilégiées / Autres communiqués
GenSight Biologics obtient une autorisation d'accès compassionnel en France pour GS010/LUMEVOQ dans le traitement de la NOHL liée à la mutation ND4

Thérapie Génique GenSight Biologics NOHL GS010/LUMEVOQ Autorisation D'accès Compassionnel
PRESS RELEASE

published on 12/22/2025 at 07:00, 4 months 19 days ago

Ipsen élargit son portefeuille de produits en développement précoce avec un conjugué anticorps-médicament innovant développé par Simcere Zaiming
Ipsen acquiert les droits mondiaux pour le développement du conjugué anticorps-médicament SIM0613 ciblant la protéine LRRC15. Lancement prévu en Phase I au second semestre 2026

Oncologie Ipsen Conjugué Anticorps-médicament SIM0613 LRRC15
PRESS RELEASE

published on 12/22/2025 at 04:30, 4 months 19 days ago

DFSK Officially Enters the Egyptian Market with Strategic Vehicle Lineup
DFSK officially enters the Egyptian market with the launch of strategic vehicle lineup, including model E5 PLUS, marking a milestone in the brand's global expansion and commitment to new energy mobility

Global Expansion DFSK Egyptian Market Strategic Vehicle Lineup New Energy Mobility
PRESS RELEASE

published on 12/22/2025 at 00:35, 4 months 19 days ago

Samsung to Host Series of Tech Forums at CES 2026
Samsung Electronics to host four moderated Tech Forum panel discussions at CES 2026 to explore AI, Home Appliances, Services, and Design trends with industry experts

Technology Industry CES 2026 AI Trends Samsung Electronics Tech Forum

Accesswire

Published on 05/09/2026 at 01:55, 1 day 8 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 9 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 9 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 10 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 11 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/09/2026 at 19:05, 15 hours 47 minutes ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 14 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 15 hours ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 15 hours ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 1 day 16 hours ago

Designated Person Notification

Les Echos

Published on 05/07/2026 at 19:15, 2 days 15 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 15 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 15 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 15 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 15 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE